Tiotropium (as bromide monohydrate) 18mcg/cap; dry pwd in caps for oral inhalation; with inhaler device. Spiriva Handihaler consists of Spiriva capsules and the Handihaler device. Spiriva capsules ...
Spiriva (tiotropium bromide) is a prescription drug that’s used to treat COPD and asthma. The drug comes in an inhaler. It’s usually used once per day. Spiriva is a prescription drug that comes in two ...
Tiotropium (as bromide monohydrate) 1.25mcg, 2.5mcg; per actuation; inh spray; contains benzalkonium chloride. Spiriva Respimat Inhalation Spray is supplied in a carton containing one Spiriva Respimat ...
SPIRIVA RESPIMAT Inhalation Spray is now available by prescription through retail pharmacies across the United States for the long-term, once-daily maintenance treatment of bronchospasm associated ...
Spiriva (tiotropium) is a prescription drug used to treat certain lung conditions. Spiriva can cause side effects that range from mild to serious. Examples include cough and dry mouth. Spiriva ...
Long-term, Head-to-Head Study Showed SPIRIVA HandiHaler (tiotropium bromide inhalation powder) Significantly Prolonged Time to First Moderate or Severe COPD Exacerbation versus Salmeterol HFA-MDI The ...
INGELHEIM AM RHEIN, Germany & NEW YORK, N.Y., USA--(BUSINESS WIRE)--Results of the one-year Prevention Of Exacerbations with Tiotropium in COPD (POET-COPD ®) study, published today by the New England ...
ORLANDO, Fla., May 24 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. and Pfizer Inc announced today that Spiriva(R) HandiHaler(R) (tiotropium bromide inhalation powder), a new option for ...
DUBLIN--(BUSINESS WIRE)--The "Spiriva" report has been added to ResearchAndMarkets.com's offering. Spiriva (tiotropium; Boehringer Ingelheim) is a long-acting muscarinic antagonist (LAMA) approved for ...
RIDGEFIELD, Conn. & NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) Pulmonary-Allergy Drugs Advisory Committee voted 11 to 1 that clinical data included in a supplemental new ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results